Literature DB >> 16209920

Tumour suppressor retinoblastoma protein Rb: a transcriptional regulator.

Liang Zhu1.   

Abstract

Rb was the first tumour suppressor identified through human genetic studies. The most significant achievement after almost twenty years since its cloning is the revelation that Rb possesses functions of a transcription regulator. Rb serves as a transducer between the cell cycle machinery and promoter-specific transcription factors. In this capacity, Rb is best known as a repressor of the E2F/DP family of transcription factors, which regulate expression of genes involved in cell proliferation and survival. An equally important aspect of Rb as a transcription regulator is that Rb also activates certain differentiation transcription factors to promote cellular differentiation. The molecular mechanisms behind the repressive effects of Rb on E2Fs have come to light in significant details, while those relating to Rb activation of differentiation transcription factors are much less understood. Finally, it has become clear that there are other aspects to Rb function that are not immediately related to transcription regulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209920     DOI: 10.1016/j.ejca.2005.08.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  24 in total

1.  E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation.

Authors:  Patrik Asp; Diego Acosta-Alvear; Mary Tsikitis; Chris van Oevelen; Brian David Dynlacht
Journal:  Genes Dev       Date:  2009-01-01       Impact factor: 11.361

2.  Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells.

Authors:  Nicola Alessio; Wolfgang Bohn; Verena Rauchberger; Flavio Rizzolio; Marilena Cipollaro; Michael Rosemann; Martin Irmler; Johannes Beckers; Antonio Giordano; Umberto Galderisi
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

3.  Nuclear Prohibitin3 Maintains Genome Integrity and Cell Proliferation in the Root Meristem through Minichromosome Maintenance 2.

Authors:  Ruihua Huang; Si Shu; Mengling Liu; Chao Wang; Bei Jiang; Jieming Jiang; Chengwei Yang; Shengchun Zhang
Journal:  Plant Physiol       Date:  2019-01-23       Impact factor: 8.340

4.  Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin.

Authors:  Marlon Stoeckius; Anna Erat; Tatsuya Fujikawa; Makoto Hiromura; Anna Koulova; Leo Otterbein; Cesario Bianchi; Edda Tobiasch; Yossi Dagon; Frank W Sellke; Anny Usheva
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

5.  Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain.

Authors:  Mei-Yi Wu; Ting-Fen Tsai; Arthur L Beaudet
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

6.  Mdm2 and tumorigenesis: evolving theories and unsolved mysteries.

Authors:  Emir Senturk; James J Manfredi
Journal:  Genes Cancer       Date:  2012-03

7.  Cooperative activation of tissue-specific genes by pRB and E2F1.

Authors:  Stephen Flowers; Fuhua Xu; Elizabeth Moran
Journal:  Cancer Res       Date:  2013-01-22       Impact factor: 12.701

8.  Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.

Authors:  Xia Zhou; Lucy X Fan; William E Sweeney; John M Denu; Ellis D Avner; Xiaogang Li
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

9.  Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure.

Authors:  Claudia Andreu-Vieyra; Ruihong Chen; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2008-07-03

10.  Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1.

Authors:  Sharon Wong; Jason D Weber
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.